Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Evotec SE buy Wolf_of_WS

Start price
€3.35
14.07.26 / 50%
Target price
-
14.07.27
Performance (%)
3.76%
Price
€3.48
17.07.26
Summary
This prediction is currently active. With a performance of 3.76%, the BUY prediction by Wolf_of_WS for Evotec SE is trending in the right direction. This prediction currently runs until 14.07.27. The prediction end date can be changed by Wolf_of_WS at any time. Wolf_of_WS has 50% into this prediction

Evotec is a German-based biotech company that provides drug discovery and development solutions to pharmaceutical and biotechnology companies. The company operates in the fields of neuroscience, immunology, oncology, and infectious diseases, and its services include hit identification, target validation, and preclinical and clinical development. Evotec has partnerships with major pharmaceutical companies and has developed its own pipeline of drugs, with a focus on developing treatments for conditions such as Alzheimer's disease and diabetes. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of approximately €5.5 billion.

Performance without dividends (%)
Name 1w
Evotec SE 3.76%
iShares Core DAX® -1.087%
iShares Nasdaq 100 -2.463%
iShares Nikkei 225® -5.371%
iShares S&P 500 -0.197%

Comments by Wolf_of_WS for this prediction

In the thread Evotec AG diskutieren

Buy Evotec SE